Recombinant Human BDKRB2 Protein，His

BDKRB2, also known as the bradykinin B2 receptor, is a G-protein coupled receptor that plays a significant role in various physiological processes, including inflammation, pain sensation, and vasodilation. Its relevance has been underscored in numerous studies linking it to cardiovascular disease, neuropathic pain, and other pathological conditions. The receptor interacts with the peptide bradykinin, initiating a cascade of cellular responses that modulate local and systemic effects in the body. Research on BDKRB2 recombinant proteins has gained momentum due to their potential therapeutic applications, including in pain management and the treatment of ischemic conditions. By producing and studying BDKRB2 in recombinant systems, researchers aim to elucidate the receptor’s structure-function relationship, explore its signaling pathways, and identify potential drug candidates that can selectively target BDKRB2. Moreover, as BDKRB2 is involved in the body’s response to injury and infection, understanding its mechanisms can provide insights for developing novel anti-inflammatory and analgesic therapies. The advancements in recombinant protein technology facilitate the detailed characterization of BDKRB2, paving the way for innovative approaches in drug discovery and therapeutic interventions targeting this crucial receptor in various diseases.